Clinical research has shown that patients with silicosis exhibit elevated levels of soluble Fas in serum and peripheral blood mononuclear cells, as well as higher levels of other FAS transcript variants and reduced membrane Fas expression in lymphocytes (Otsuki et al., 2006). Here, FAS is linked to silicosis.